共 324 条
[1]
Arbyn M(2010)European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition–summary document Ann Oncol 21 448-458
[2]
Anttila A(2011)Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test J Clin Microbiol 49 2643-2650
[3]
Jordan J(2012)Colposcopic management of abnormal cervical cytology and histology J Obstet Gynaecol Can 34 1188-1202
[4]
Ronco G(2006)Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline/mildly dyskaryotic smear Cancer Epidemiol Biomarkers Prev 15 1268-1273
[5]
Schenck U(2009)A review of human carcinogens-Part B: biological agents Lancet Oncol 10 321-322
[6]
Segnan N(2010)Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical cancer lesions Cancer Epidemiol Biomarkers 19 1668-1674
[7]
Wiener H(2005)Triage with human papilloma virus testing of women with cytologic abnormalities prompting referral for colposcopy assessment Cancer Cytopathol 105 2-7
[8]
Herbert A(2005)Reproducibility of HPV DNA testing by hybrid capture 2 in a screening setting Am J Clin Pathol 124 716-721
[9]
von Karsa L(2008)Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial Lancet Oncol 9 937-945
[10]
Benevolo M(2013)Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial Lancet Oncol 14 168-176